Leading a technology organization is no easy task. Technology leaders find themselves navigating an ever-changing business landscape, balancing competing priorities, keeping abreast of evolving technological innovations and operating within changing organizational constraints.
Outside perspective from operators who have “sat in the hot seat” can help organizations embrace and capitalize on the growing impact of technology on their business.
Boards, executives and technology leaders (CIO, CTO, CDO) call on A&M when objective counsel and advice can be the difference between success and failure for their most important technology-enabled initiatives.
How A&M Can Help:
A&M helps guide client technology organizations through periods of significant change and strategic importance. We’ve assembled a team of former CIOs and CTOs that have the sensitivity that comes from front line experience. They know the questions to ask, can identify potential roadblocks to success, and can provide objective, independent advice and interim leadership for mission critical results.
Core services include:
- IT Leadership for Business Transformation
- IT Strategy Aligned with Business Outcomes
- Organizational Design and Transition
- Interim CIO / CTO
Contact Us Now
Board and C‑Suite Call to Action: Seize Resilience ROI With a Strategic Cyber Insurance Playbook
June 30, 2025
Managing Directors Vincent Mekles and Joe Shepley outline key steps organizations should take to proactively address the new Rule including how to assess employee and vendor risk and build defensible compliance controls.
Capital Efficiency Revolution: How Sidecars Are Transforming P&C Insurance Investment
June 30, 2025
In the second article of a four-part series, the Insurance sector within the Financial Services Industry Group explores how reinsurance sidecars are delivering historic returns.
The U.S. Pharma Premium: Who’s Really Paying the Price?
June 30, 2025
For decades, the United States has shouldered a disproportionate share of global pharmaceutical costs, accounting for 70% of global biopharma profits and over 80% of new drug launches. While this has helped drive significant medical innovation and supported the majority of global drug launches, it has also resulted in higher out-of-pocket costs for American patients.
All Aboard: Executive Actions to Ensure Maritime Cyber Resilience Amid Deals and Digitization
June 30, 2025
As the maritime world sails deeper into digital waters, cyber threats are no longer just an IT issue — they’re a boardroom priority. Discover the critical actions executives must take to safeguard resilience, reputation, and deal value in a high-stakes, high-risk seascape.
